scispace - formally typeset
Open AccessJournal ArticleDOI

Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis

TLDR
MR imaging-PDFF showed promise for assessment of hepatic steatosis grade in patients with NAFLD, and was significantly correlated with histologic steatotic grade.
Abstract
MR imaging with proton density fat fraction (PDFF) permitted high overall accuracy with moderate sensitivity and high specificity for classification of dichotomized steatosis grade, and these results support the conduct of further studies to help validate MR imaging–PDFF as a biomarker of hepatic steatosis in nonalcoholic fatty liver disease.

read more

Citations
More filters
Journal ArticleDOI

Management and diagnosis of fatty liver disease.

TL;DR: Given the proven benefit of weight loss, there may be reason to screen at-risk populations; however, limited availability of other disease-modifying treatments may limit the cost–benefit ratios.
Journal ArticleDOI

Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease

TL;DR: LS assessed by MRE is associated with hepatic decompensation and death, and the MEFIB combination of MRE with FIB-4 may have high negative predictive value for liver-related events.
Journal ArticleDOI

MRI detects peripheral nerve and adjacent muscle pathology in non-systemic vasculitic neuropathy (NSVN).

TL;DR: The data provide a proof of concept that MRI can render information about nerve integrity and muscle pathology in NSVN and further studies are warranted to evaluate DTI and multiecho Dixon MRI as surrogate markers in NSvN.
Book ChapterDOI

Diffuse Liver Disease: Cirrhosis, Focal Lesions in Cirrhosis, and Vascular Liver Disease

TL;DR: Significant advances in magnetic resonance imaging and MR elastography allow quantification of hepatic steatosis and fibrosis before end-stage liver disease and emerge as noninvasive screening and monitoring tools as an alternative to liver biopsy.
References
More filters
Journal ArticleDOI

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

TL;DR: There are no systems for grading necroinflammatory activity or for staging fibrosis as exist for various other forms of chronic liver disease and this study proposes a grading and staging system that reflects the unique histological features of nonalcoholic steatohepatitis.
Journal ArticleDOI

Sampling variability of liver fibrosis in chronic hepatitis C.

TL;DR: It is suggested that a length of at least 25 mm is necessary to evaluate fibrosis accurately with a semiquantitative score, because variability in the distribution of fibrosis within the liver is a major limitation when using more accurate methods such as automated image analysis.
Journal ArticleDOI

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

TL;DR: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.
Related Papers (5)